Old Web
English
Sign In
Acemap
>
authorDetail
>
Eniola Ogunmefun
Eniola Ogunmefun
Princeton University
Mogamulizumab
Medicine
CCR4
Monoclonal antibody
Human study
2
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
287 Safety and antitumor activity of indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors
2020
Journal for ImmunoTherapy of Cancer
Solmaz Sahebjam
Jameel Muzaffar
Timothy A. Yap
David S. Hong
Olivier Rixe
Ursa Brown-Glaberman
Andreea Varga
Christophe Massard
Capucine Baldini
Sergey Efuni
Barbara Kapelan
Yi. Liu
Eniola Ogunmefun
Tomonori Tayama
Henry Zhao
Denis Healy
Robert Latek
Daisuke Nakashima
Emrullah Yilmaz
Show All
Source
Cite
Save
Citations (0)
First-in-human study of KHK2455, a long-acting, potent and selective indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, in combination with mogamulizumab (Moga), an anti-CCR4 monoclonal antibody, in patients (pts) with advanced solid tumors.
2018
Journal of Clinical Oncology
Timothy A. Yap
Solmaz Sahebjam
David S. Hong
Vi Kien Chiu
Emrullah Yilmaz
Sergey Efuni
Dmitri O. Grebennik
Agron Collaku
Eniola Ogunmefun
Yi. Liu
Tomonori Tayama
Robert Raymond Latek
Olivier Rixe
Show All
Source
Cite
Save
Citations (6)
1